A new medication is being developed to treat severe nausea and vomiting among chemotherapy patients. The information below was generated from a small sample size ( n = 11) and shows the number of...

A new medication is being developed to treat severe nausea and vomiting among chemotherapy patients. The information below was generated from a small sample size (n
= 11) and shows the number of times a chemotherapy patient vomited both before and after treatment due to the side effects of chemotherapy. Set up and interpret the results of a sign test at the alpha equals .05 level to determine if there is a difference in symptoms before and after treatment.

1. A) We fail to reject H₀, which states the median difference in the number of vomiting episodes in a day before and after treatment are equal because 1 is less or equal to critical value 1 for a sign test with a population of only 11 individuals.


2. B) We fail to reject H₀, which states the median difference in the number of vomiting episodes in a day before and after treatment are equal because 10 is greater or equal to the critical value 1 for a sign test with a population of only 11 individuals.


3. C) We reject H₀
   in favor of H₁, which states the median difference in the number of vomiting episodes in a day before and after treatment are not equal because 1 is less or equal to the critical value 1 for a sign test with a population of only 11 individuals.


4. D) We reject H₀
   in favor of H₁, which states the median difference in the number of vomiting episodes in a day before and after treatment are not equal because 10 is greater or equal to the critical value 1 for a sign test with a population of only 11 individuals.